TNFRSF10B and cancer: Second, cancer cells are known to have altered phospholipid and cholesterol content in the plasma membrane86–88 and we have shown this can alter DR5 clustering and activity.32 Even without these potential improvements, the success we have shown here with nimesulide suggests that the existing platform holds promise for ongoing efforts to study small molecule activators of DR5.